Trial Outcomes & Findings for Evaluation of the Performance of the Motus Cleansing System (MCS) (NCT NCT03026075)

NCT ID: NCT03026075

Last Updated: 2019-02-11

Results Overview

The rate of adequate cleansing level per subject will be evaluated by the Boston Bowel Preparation (BBPS) scoring index before and post the cleansing operation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

47 participants

Primary outcome timeframe

Up to 2 hours

Results posted on

2019-02-11

Participant Flow

patients indicated for screening/ surveillance or diagnosis colonoscopy enrolled at 3 clinical sites as follows: * Radboud University Medical Center(UMC)- Netherlands-16 cases * Erasmus Medical Center (MC)-Netherlands-16 cases * Mainz University Medical Center(UMC)-Germany- 15 cases enrollment period : 20 December 2016 - 31 May 2017

The patients had reduced preparation in order to mimic poor bowel cleansing. the study bowel preparation consisted of dietary restrictions (no dried fruit, seeds or nuts) starting 2 days prior to colonoscopy, a 24-hour clear liquid diet and a split dose of 20 mg Bisacodyl (10 mg in each dose).

Participant milestones

Participant milestones
Measure
Colonoscopy With MCS
Standard colonoscopy procedure with Motus Cleansing System Motus Cleansing System (MCS): The MCS enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter \& fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.
Overall Study
STARTED
47
Overall Study
COMPLETED
46
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Colonoscopy With MCS
Standard colonoscopy procedure with Motus Cleansing System Motus Cleansing System (MCS): The MCS enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter \& fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.
Overall Study
Physician Decision
1

Baseline Characteristics

Evaluation of the Performance of the Motus Cleansing System (MCS)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Colonoscopy With MCS
n=47 Participants
Standard colonoscopy procedure with Motus Cleansing System Motus Cleansing System (MCS): The MCS enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter \& fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.
Age, Continuous
56.9 years
STANDARD_DEVIATION 11.8 • n=5 Participants
Sex: Female, Male
Female
27 Participants
n=5 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · White Non-Hispanic
44 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Hispanic
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Asian
1 Participants
n=5 Participants
Region of Enrollment
Netherlands
32 participants
n=5 Participants
Region of Enrollment
Germany
15 participants
n=5 Participants
Body Mass Index (BMI)
26.0 kg/m^2
STANDARD_DEVIATION 4.0 • n=5 Participants

PRIMARY outcome

Timeframe: Up to 2 hours

Population: the bowel preparation level before and after the use of Motus Cleansing System was evaluated using the Boston Bowel Preparation Scale (BBPS) where patients consider to have adequate cleansing level if all 3 colon segments graded 2 or 3 ( good or excellent)

The rate of adequate cleansing level per subject will be evaluated by the Boston Bowel Preparation (BBPS) scoring index before and post the cleansing operation.

Outcome measures

Outcome measures
Measure
Colonoscopy With MCS
n=46 Participants
Standard colonoscopy procedure with Motus Cleansing System Motus Cleansing System (MCS): The MCS enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter \& fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.
Performance of MCS in Cleansing a Poorly Prepared Colon.
adequate cleaning after the use of MCS
46 Participants
Performance of MCS in Cleansing a Poorly Prepared Colon.
adequate cleaning at baseline
9 Participants

Adverse Events

Colonoscopy With MCS

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Colonoscopy With MCS
n=47 participants at risk
Standard colonoscopy procedure with Motus Cleansing System Motus Cleansing System (MCS): The MCS enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter \& fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.
Gastrointestinal disorders
Bloating
10.6%
5/47 • Number of events 5 • Follow up was conducted immediately after the procedure before patient discharge and at 2-3 days and 14-16 days post procedure

Additional Information

Ravit Peled -Director of Clinical Trial

Motus GI Medical Technologies Ltd.

Phone: 0733243823

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place